skip to Main Content
MedMen Acquires Illinois Dispensary, Continues its U.S. Expansion

PRESS RELEASE

Acquisition Grows Brand’s Presence to Country’s Three Largest Metropolitan Areas

LOS ANGELES (October 3, 2018) – MedMen Enterprises Inc. (“MedMen” or the”Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) today announced that it has signed a definitive agreement (the “Agreement”) to acquire Seven Point, a licensed medical cannabis dispensary located in the historic Chicago suburb of Oak Park, Illinois.

Illinois is one of the fastest growing medical marijuana markets in the country. Since the beginning of the year the number of qualifying patients increased 41 percent to 42,203, and retail cannabis sales grew 35 percent, according to the state. Illinois also expanded its medical cannabis program recently to allow people who have been prescribed opioids the opportunity to obtain temporary medical cannabis cards.
“This acquisition brings the MedMen brand to yet another major stage,” said MedMen CEO and Co-founder Adam Bierman. “MedMen has established a presence in the primary markets of California, Nevada and New York. Our strategy has been to put our brand in high visibility commercial districts in popular locations like Beverly Hills, Manhattan, Las Vegas, and Oak Park, just outside Chicago, fits the mold perfectly.”
Seven Point is located in a high foot traffic shopping district among popular restaurants, cafes and major retailers like Whole Foods, Gap and Pier 1. This week, MedMen also announced the acquisition of a medical marijuana dispensary in Scottsdale, Arizona, as well as cultivation and processing operations. Currently, MedMen operates dispensaries in three states, including seven in the Los Angeles area and one in Manhattan.
“Seven Point is proud of its strong commitment to the local medical patient community and the loyal following we have built over the years,” said Brad Zerman, chief executive of Seven Point. “MedMen will continue that tradition while bringing its industry-leading retail operations and commitment to quality and service.”
As consideration for the acquisition, the Company will pay a combination of cash at closing, deferred cash and shares of MedMen Enterprises, Inc., an amount not deemed material. The transaction is expected to close within 90 days and is subject to customary closing conditions, including state approval.
ABOUT MEDMEN:
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. Visit http://www.medmen.com.
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, information concerning the proposed acquisition, expectations regarding whether the proposed acquisition will be consummated, including whether conditions to the consummation of the proposed acquisition will be satisfied and whether the proposed acquisition will be completed on the current terms, the timing for completing the proposed acquisition, expectations for the effects of the proposed acquisition or the ability of the Company to successfully achieve business objectives, expectations regarding the Illinois cannabis market and expectations for other economic, business, and/or competitive factors.
 
By identifying such information and statements in this manner, MedMen is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedMen to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, MedMen has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability to consummate the proposed acquisition; the ability to obtain requisite regulatory approvals and third party consents and the satisfaction of other conditions to the consummation of the proposed acquisition on the proposed terms and schedule; the potential impact of the announcement or consummation of the proposed acquisition on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the proposed acquisition. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
 
Although MedMen believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to MedMen or persons acting on its behalf is expressly qualified in its entirety by this notice.
MEDIA CONTACT:
Briana Chester
Senior Publicist
(424) 888-4260
INVESTOR RELATIONS CONTACT:
Stéphanie Van Hassel
Head of Investor Relations
(323) 705-3025
This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

State considers social equity licenses for people impacted by ‘war on drugs’ to get cannabis shop licenses

SEATTLE – The Washington State Liquor Cannabis Board is considering a point system that would give people convicted of a drug-related crime and did prison time – preferential treatment when applying for retail cannabis license. If adopted, the City of Seattle will adopt the same rules and set aside $1 million dollars in grant money…

Majority of RI cities and towns will vote on recreational marijuana sales

Thirty-one of Rhode Island’s 39 cities and towns will ask voters whether to allow the sale of recreational marijuana within their borders, the secretary of state’s office said Thursday. In May, Rhode Island became the 19th state to legalize adult-use recreational marijuana, with sales starting Dec. 1. The state plans to license 24 new retail shops…

Arkansas Supreme Court issues provisional order placing recreational marijuana amendment back on ballot

Conditional certification stipulated The Arkansas Supreme Court on Wednesday granted a petition to allow a proposed constitutional amendment that would legalize recreational marijuana back on the November ballot until it decides how to proceed with the Arkansas Board of Election Commissioners’ decision to not approve its ballot title. The Arkansas Supreme Court stated in court…

Sweeping cannabis bill becomes law, after yearslong effort on reforms

Vetoes study on medical marijuana in schools Governor Charlie Baker on Thursday signed into law a package of significant reforms to the state’s multibillion-dollar marijuana industry, capping a yearslong campaign by advocates, entrepreneurs, and regulators to rewrite the rules of cannabis commerce in Massachusetts. While officials said key aspects of the bill could take a…

More Categories

Back To Top
×Close search
Search